Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates

Immunome, Inc. (IMNM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of$ 0.68. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -23.53%. A quarter ago, it was expected that this company would post a loss of$ 0.60 per share when it actually produced a loss of $0.78, delivering a surprise of -30%.Over the last four quarters, the company has surpassed ...